For the first time, domesticated meat has received approval in the United States. A business named Upside Foods will soon be permitted to sell chicken created from genuine animal cells grown in bioreactors instead of needing to kill live animals according to a ruling issued by the Food and Drug Administration (FDA).
Just two more minor regulatory measures need to be taken before consumers can purchase grown meat. Before food from Upside may be sold in the US, it must first receive a mark of inspection from the US Department of Agriculture (USDA) and a grant of inspection from Upside’s production facilities. The FDA’s lengthy premarket consultation procedure, which led to the approval, is likely to be significantly shorter than these two procedures’ anticipated completion times.
As Upside Foods moves closer to commercialization, the company has achieved a number of significant milestones, including a $400 million Series C funding round that increased their valuation to over $1 billion, the acquisition of the cultured seafood company Cultured Decadence, a partnership with the three-Michelin starred chef Dominique Crenn, and the opening of its Engineering, Production, and Innovation Center (EPIC), one of the most cutting-edge cultivated meat production facilities in the world.